630 results
Transcatheter mitral valve implantation (TMVI) in patients with severe mitral annular calcification: early results from the Tendyne MAC Study
Watch this video if you want to know more about the feasibility study of Tendyne mitral valve system in mitral annular calcification.
Speaker: Paul Sorajja
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
How does the latest Tendyne TMVI clinical evidence change heart team decisions?
Watch this video if you want to get an overview of the 2-years results of the largest Transcatheter Mitral Valve Implantation (TMVI) clinical study and discuss the implications of the results for heart team's decisions.
Speaker: David Muller
Essential reading for understanding data in meta-analyses
23 Mar 2020
A good systematic review and meta-analysis can be a great help in sorting out apparently conflicting studies. But the results of meta-analyses themselves can vary. We need more people to be able to read them critically, and to see why meta-analyses become conflicting results themselves.
Cases in Japanese - PCI, MR & TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: PCI for coronary ischemia after EvolutR implantation, degenerative mitral regurgitation with large gap, bailout of ventricular septal defect after TAVI, and more!
Strategies to handle complications during interventions for structural heart disease: my worst nightmare - Part 1
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn all about how to handle and avoid complications during interventions for structural heart disease, such as TAVI valve emboli, intra-aortic balloon occlusion, mitral leaflet tear, and more!
MitraClip and challenging anatomies
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn from a selection of challenging Mitraclip cases, how to avoid and cope with various complications, such as single-leaflet device attachment and leaflet tear, mitral stenosis, chordal entanglement, and more!
Mitral and tricuspid valves: new technologies on the horizon
16 Feb 2020 – From PCR Tokyo Valves 2020
Learn about up-to-date data regarding new mitral and tricuspid percutaneous techniques and future repair technologies...
Beyond the evolution! Latest image guided therapy for structural heart disease intervention 2.0 era
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session in japanese to learn more about EchoNavigator, an innovative tool for guidance of interventional procedures in structural heart disease, and discover how it may help you achieve a better patient outcome.
